Dr Lal Pathlabs Reports Strong Financial Results, Highlights Growth in Profitability and Non-Operating Income in March 2025
Dr Lal Pathlabs has announced its financial results for the quarter ending March 2025, highlighting a significant increase in Profit After Tax (PAT) to Rs 154.80 crore, an 83.2% year-on-year rise. Profit Before Tax (PBT) also grew to Rs 127.60 crore, while Earnings per Share (EPS) reached Rs 18.52.
Dr Lal Pathlabs has reported its financial results for the quarter ending March 2025, showcasing a notable performance within the Hospital & Healthcare Services industry. The company's evaluation has undergone a revision, reflecting a shift in its score to 11 from 4 over the past three months.The financial data reveals a significant growth in Profit After Tax (PAT), which reached Rs 154.80 crore, marking an 83.2% increase year on year. This figure represents the highest PAT recorded in the last five quarters, indicating a strong near-term trend. Similarly, Profit Before Tax (PBT) also demonstrated positive movement, amounting to Rs 127.60 crore, with a year-on-year growth of 25.71%. The Earnings per Share (EPS) reached Rs 18.52, the highest in the last five quarters, suggesting enhanced profitability for shareholders.
However, it is important to note that the company reported its highest Non-Operating Income at Rs 25.80 crore in the last five quarters. This increase, derived from non-business activities, raises questions about its sustainability moving forward.
For further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
